Developer docs
API playgroundTry for free, no card

Search company profiles

Helaina

Full company profile

uuid000032a

Namestring
Helaina
Legal namestring
Helaina Inc.
Websiteurl
myhelaina.com
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Helaina is a privately held, venture-backed biotechnology company founded in 2019 by food scientist Laura Katz and headquartered in New York City. The company uses a proprietary precision fermentation platform — engineered yeast programmed with human genetic instructions and fermented in 75,000-liter bioreactors at over 99% purity — to produce bio-identical human proteins, with its first commercial product being effera® human lactoferrin. The R&D operating system behind the platform follows a four-step process (Design, Build, Assess, Scale), leverages machine learning models trained on over 170 million data points, and is supported by 49 patents and a multidisciplinary team of more than 35 scientists including 15 PhDs.

Helaina's business is B2B: the company sells effera® as a proprietary ingredient to consumer brand partners and formulators across women's health, infant and child nutrition, active nutrition, gut health, and longevity, with approximately 12 finished commercial products on market by early 2026 and an average of one new product launch per month. Pricing is quote-based and not publicly disclosed, with revenue generated through B2B ingredient sales and strategic co-development partnerships — most notably a multi-year collaboration with Nestlé for early-life nutrition announced in June 2026.

The company has raised $83 million+ across four funding rounds, including a $20 million Series A in 2021 (Spark Capital and Siam Capital) and a $45 million Series B in 2024 (Avidity Partners). Helaina reached metric-ton scale manufacturing in 2025, producing more than 10 million efficacious servings per fermentation run, and is positioning effera® as a clean-label, dairy-free, allergen-free alternative to bovine lactoferrin that the human immune system recognizes as self — supported by clinical evidence including a 28-day safety study showing zero antibody production. International expansion has begun through a Mitsubishi International Food Ingredients distribution partnership and brand partners entering European markets.

Short descriptiontext

Helaina is a New York-based biotechnology company that uses precision fermentation to produce effera®, the world's first bio-identical human lactoferrin, selling the proprietary B2B ingredient to consumer brands and enterprise nutrition partners across women's health, infant nutrition, active nutrition, gut health, and longevity.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
precision fermentation proteins, bio-identical lactoferrin, human milk proteins, bioactive protein ingredients, functional nutrition ingredients
Industry2 codes
PRIMARYAFAKAKAJ
Infant Formula & Specialized Dairy Nutrition Manufacturing
SECONDARYAFAHAHAJ
Specialized Dairy Nutrition Base Powder & Premix Manufacturing (Vitamin/Mineral/Functional Premixes)
Agriculture & Food Production/Dairy Processing/Infant Formula & Specialized Dairy Nutrition Manufacturing
NAICS code2 codes
  • Dairy Product Manufacturing3115
  • Dairy Product (except Frozen) Manufacturing31151
SIC code2 codes
  • Dairy Products2020
  • Food And Kindred Products2000
Product category
Bioactive Protein Ingredients
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1B2B ingredient sales (effera® human lactoferrin)
TypeTransaction Fee
Description

Helaina sells its proprietary effera® bio-identical human lactoferrin as a B2B ingredient to brands and formulators in functional foods, beverages, and dietary supplements. Recurring purchase model as brand partners reorder ingredient for their commercial production runs; tier-tonnage production at scale (10 million+ efficacious servings per run).

agfundernews.com
2Strategic co-development partnerships / licensing
TypeLicensing Royalties
Description

Multi-year strategic innovation collaborations with major nutrition companies (e.g., Nestlé) for early-life nutrition applications. Revenue likely structured as milestone payments, joint development funding, and/or long-term offtake/supply agreements tied to commercialization.

myhelaina.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain
Pricing details1 tier
1Quote-based / Not publicly disclosed for effera® ingredient
ModelOtherBilling cadencePay-as-you-go
Notes

Pricing is quote-based and negotiated with brand/formulator customers; not listed publicly. Volume-based on orders (kilograms to metric tons). Standard net 30 payment terms in USD.

myhelaina.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1effera
Description

Helaina's proprietary bio-identical human lactoferrin ingredient brand, produced via precision fermentation. Marketed as the world's first bio-identical lactoferrin — functionally equivalent to the protein found in human milk — and sold as a B2B ingredient to consumer brands in women's health, active nutrition, infant & child nutrition, and gut health.

myhelaina.com
Core offering1 text field

Helaina produces and sells effera®, the world's first bio-identical human lactoferrin, manufactured via proprietary precision fermentation. The company operates a B2B ingredient model, supplying brand formulators and consumer packaged goods companies in women's health, sports and active nutrition, infant and child nutrition, gut health, and longevity. A flagship multi-year strategic collaboration with Nestlé extends the platform's reach into early-life nutrition.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 63% reduction in inflammation across all donors in ex vivo human immune cell studies
+5 more records
Product overview1 text field

Helaina's offering centers on a single flagship bioactive ingredient, effera® human lactoferrin, produced by a proprietary precision fermentation platform. The platform (Design → Build → Assess → Scale) is the technology foundation that enables effera® and its planned pipeline of additional bio-identical human milk proteins; effera® itself is deployed across four labeled application segments — Women's Health, Sports & Active Nutrition, Infant & Child Nutrition, and Gut Health — and is sold B2B to brand partners and formulators (e.g., through the Nestlé multi-year collaboration and consumer products such as Amulet Daily Cycle Support, Kroma Wellness Super Core, Levelle, Desert Harvest, Healthgevity ImmunoRestore+, Kepos, Sunny Within, The Feed Swiss Rx Revitalize, VEEP Nutrition, Vital Nutrients, Silver Fern, and Vital Woman).

Product and service2 records
1effera® (Bio-Identical Human Lactoferrin)
CategoryBioactive Protein Ingredients / Functional Nutrition Ingredients
Description

effera® is the world's first bio-identical human lactoferrin, precision-fermented to be structurally and functionally equivalent to the lactoferrin in mother's milk. Sold B2B to brand formulators in women's health, active nutrition, infant & child nutrition, gut health, longevity, and personal care, with claimed 63% reduction in inflammation in ex vivo studies and 400% better uptake than bovine lactoferrin. The brand is trademarked and is Helaina's flagship product.

2Helaina Precision Fermentation Platform
CategoryBiotechnology / Precision Fermentation Platform
Description

Proprietary four-step R&D operating system (Design → Build → Assess → Scale) that programs yeast with human genetic instructions to produce bio-identical human proteins. Leverages 170M+ data points of machine learning, advanced robotics and mass spectrometry for parallel strain characterization, and 75,000-liter commercial-scale bioreactors achieving over 99% purity. Operated by 35+ scientists (including 15 PhDs) at Helaina's New York City facility.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership14 partners
1Nestlé
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-06-02
Description

Multi-year strategic innovation collaboration announced June 2, 2026 to explore the role of new bioactive proteins in early-life nutrition. Pairs Nestlé's expertise in infant nutrition research and innovation with Helaina's precision fermentation platform. Part of Nestlé's broader open innovation strategy. Isabel Bureau-Franz (Head of Nestlé Product Technology Center for Nutrition & Health) and Laura Katz (Helaina Founder/CEO) are quoted publicly. Also covered in WSJ exclusive interview.

myhelaina.com
Strategic tierFlagshipTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-04-13
Description

Squared Circles (partnered with L Catterton) launched Amulet in April 2026 with Daily Cycle Support — a biotech supplement containing bio-identical lactoferrin (effera®) plus creatine. Investors include Maria Sharapova and Gabriela Hearst. Featured on Helaina's Where to Buy page.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-01-01
Description

Consumer brand partner that has launched products formulated with effera® (e.g., Super Core dairy-free colostrum and related longevity/immunity products). Listed on Helaina's 'Where to Buy' page and featured in Forbes (August 2025).

4The Feed
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-01-01
Description

Consumer brand partner selling products formulated with effera® (e.g., Swiss Rx Revitalize supplement for performance/recovery). Featured on Helaina's 'Where to Buy' page.

foodbusinessnews.net
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-01-01
Description

Distribution/ingredient channel partner for effera® in international markets, leveraging Mitsubishi's global food ingredients network.

6Healthgevity
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Consumer brand partner selling ImmunoRestore+ supplement powered by effera®, featured on Helaina's 'Where to Buy' page.

myhelaina.com
7Vital Woman
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Consumer brand partner selling 'Human Nature' monthly supplement powered by effera® for women's health, featured on Helaina's 'Where to Buy' page.

myhelaina.com
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Consumer brand partner selling 'Human Milk Prebiotic Superfood' (human milk-equivalent) powered by effera®, featured on Helaina's 'Where to Buy' page.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Consumer brand partner selling 'Longevity' watermelon-lime liposomal supplement powered by effera®, featured on Helaina's 'Where to Buy' page.

10Desert Harvest
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Consumer brand partner selling 'Human Lactoferrin with SSAV' supplement for menopause support powered by effera®; entered European menopause market September 2025. Featured on Helaina's 'Where to Buy' page.

myhelaina.com
11VEEP Nutrition
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Consumer brand partner selling 'Immunity Code Young Gut Ultra' supplement powered by effera®, featured on Helaina's 'Where to Buy' page.

myhelaina.com
12Levelle
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Consumer brand partner selling cycle-syncing plant-based protein (Boom Chocolata) powered by effera®, featured on Helaina's 'Where to Buy' page.

myhelaina.com
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Consumer brand partner selling 'Mighty Multivitamin Without Iron' for kids using effera®, featured on Helaina's 'Where to Buy' page.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Consumer brand partner selling 'Women's Whole Food Multivitamin' formulated with effera®, featured on Helaina's 'Where to Buy' page.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight8 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Direct precision fermentation peer producing bio-identical dairy proteins (whey and casein) via engineered microorganisms; comparable B2B ingredient model, fermentation platform, and CPG brand partner go-to-market as Helaina.

TypeDirect peer
Description

Precision fermentation company producing animal-free milk proteins for food and beverage applications; overlaps with Helaina in B2B bioactive protein production using engineered yeast and similar capital-intensive scale-up profile.

TypeDirect peer
Description

Biotech developing precision-fermented lactoferrin and other human milk proteins for infant nutrition and functional foods; one of the closest direct competitors to Helaina's effera® in the bio-identical lactoferrin category.

TypeEmerging player
Description

Cellular agriculture / precision fermentation company targeting human breast milk components; comparable focus on bio-identical human milk proteins for early-life nutrition but at earlier commercial stage than Helaina.

TypeEmerging player
Description

Cellular agriculture company cultivating milk components from mammary cells; comparable mission of producing human-milk-equivalent proteins for infant formula but uses a different (cell-culture) production modality than Helaina's precision fermentation.

TypeDirect peer
Description

Israel-based precision fermentation company producing animal-free dairy proteins using engineered microbes; comparable B2B ingredient model, fermentation stack, and food/beverage brand partner strategy as Helaina.

TypeBroad incumbent
Description

One of the world's largest suppliers of bovine lactoferrin and egg-derived proteins to nutrition, supplement, and infant formula markets; direct incumbent competitor that Helaina's bio-identical human lactoferrin explicitly displaces.

TypeBroad incumbent
Description

Major dairy-ingredient supplier offering whey proteins, caseins, and lactoferrin for infant nutrition, sports nutrition, and health; broad incumbent whose bovine lactoferrin and dairy protein portfolio competes directly with effera® in B2B ingredient procurement.

TypeBroad incumbent
Description

Global ingredient supplier with a sizable lactoferrin and bioactive protein portfolio serving supplement and functional food brands; comparable B2B ingredient distribution muscle that Helaina's brand partners could alternatively purchase from.

TypeOthers
Description

Strategic partner and global nutrition/health sciences arm of Nestlé; relevant as both a customer (multi-year collaboration) and a broad incumbent defining the regulatory, formulation, and commercialization standards Helaina must meet in early-life nutrition.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers12 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors13 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Helaina

Bioactive Protein Ingredientsmyhelaina.com

Helaina is a New York-based biotechnology company that uses precision fermentation to produce effera®, the world's first bio-identical human lactoferrin, selling the proprietary B2B ingredient to consumer brands and enterprise nutrition partners across women's health, infant nutrition, active nutrition, gut health, and longevity.

What Helaina does

Helaina is a privately held, venture-backed biotechnology company founded in 2019 by food scientist Laura Katz and headquartered in New York City. The company uses a proprietary precision fermentation platform — engineered yeast programmed with human genetic instructions and fermented in 75,000-liter bioreactors at over 99% purity — to produce bio-identical human proteins, with its first commercial product being effera® human lactoferrin. The R&D operating system behind the platform follows a four-step process (Design, Build, Assess, Scale), leverages machine learning models trained on over 170 million data points, and is supported by 49 patents and a multidisciplinary team of more than 35 scientists including 15 PhDs.

Helaina's business is B2B: the company sells effera® as a proprietary ingredient to consumer brand partners and formulators across women's health, infant and child nutrition, active nutrition, gut health, and longevity, with approximately 12 finished commercial products on market by early 2026 and an average of one new product launch per month. Pricing is quote-based and not publicly disclosed, with revenue generated through B2B ingredient sales and strategic co-development partnerships — most notably a multi-year collaboration with Nestlé for early-life nutrition announced in June 2026.

The company has raised $83 million+ across four funding rounds, including a $20 million Series A in 2021 (Spark Capital and Siam Capital) and a $45 million Series B in 2024 (Avidity Partners). Helaina reached metric-ton scale manufacturing in 2025, producing more than 10 million efficacious servings per fermentation run, and is positioning effera® as a clean-label, dairy-free, allergen-free alternative to bovine lactoferrin that the human immune system recognizes as self — supported by clinical evidence including a 28-day safety study showing zero antibody production. International expansion has begun through a Mitsubishi International Food Ingredients distribution partnership and brand partners entering European markets.

Helaina firmographics

Firmographics
Name
Helaina
Legal name
Helaina Inc.
Website
https://myhelaina.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Short description
Helaina is a New York-based biotechnology company that uses precision fermentation to produce effera®, the world's first bio-identical human lactoferrin, selling the proprietary B2B ingredient to consumer brands and enterprise nutrition partners across women's health, infant nutrition, active nutrition, gut health, and longevity.
Ownership category
akta.pro rank

Helaina industry classification

Industry
Product category
Bioactive Protein Ingredients
NAICS
Dairy Product Manufacturing (3115), Dairy Product (except Frozen) Manufacturing (31151)
SIC
Dairy Products (2020), Food And Kindred Products (2000)
akta.pro industry
PRIMARYAFAKAKAJ
Infant Formula & Specialized Dairy Nutrition Manufacturing
SECONDARYAFAHAHAJ
Specialized Dairy Nutrition Base Powder & Premix Manufacturing (Vitamin/Mineral/Functional Premixes)
Agriculture & Food Production/Dairy Processing/Infant Formula & Specialized Dairy Nutrition Manufacturing

Keywords

  • Precision fermentation proteins
  • Bio-identical lactoferrin
  • Human milk proteins
  • Bioactive protein ingredients
  • Functional nutrition ingredients

Where Helaina is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Helaina business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. B2B ingredient sales (effera® human lactoferrin): Helaina sells its proprietary effera® bio-identical human lactoferrin as a B2B ingredient to brands and formulators in functional foods, beverages, and dietary supplements. Recurring purchase model as brand partners reorder ingredient for their commercial production runs; tier-tonnage production at scale (10 million+ efficacious servings per run).
  2. Strategic co-development partnerships / licensing: Multi-year strategic innovation collaborations with major nutrition companies (e.g., Nestlé) for early-life nutrition applications. Revenue likely structured as milestone payments, joint development funding, and/or long-term offtake/supply agreements tied to commercialization.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goQuote-based / Not publicly disclosed for effera® ingredient

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Helaina product offering

Product offering

Core offering

Helaina produces and sells effera®, the world's first bio-identical human lactoferrin, manufactured via proprietary precision fermentation. The company operates a B2B ingredient model, supplying brand formulators and consumer packaged goods companies in women's health, sports and active nutrition, infant and child nutrition, gut health, and longevity. A flagship multi-year strategic collaboration with Nestlé extends the platform's reach into early-life nutrition.

Product overview

Helaina's offering centers on a single flagship bioactive ingredient, effera® human lactoferrin, produced by a proprietary precision fermentation platform. The platform (Design → Build → Assess → Scale) is the technology foundation that enables effera® and its planned pipeline of additional bio-identical human milk proteins; effera® itself is deployed across four labeled application segments — Women's Health, Sports & Active Nutrition, Infant & Child Nutrition, and Gut Health — and is sold B2B to brand partners and formulators (e.g., through the Nestlé multi-year collaboration and consumer products such as Amulet Daily Cycle Support, Kroma Wellness Super Core, Levelle, Desert Harvest, Healthgevity ImmunoRestore+, Kepos, Sunny Within, The Feed Swiss Rx Revitalize, VEEP Nutrition, Vital Nutrients, Silver Fern, and Vital Woman).

Differentiator

Problem solved

Functional benefit

Brands

  • effera: Helaina's proprietary bio-identical human lactoferrin ingredient brand, produced via precision fermentation. Marketed as the world's first bio-identical lactoferrin — functionally equivalent to the protein found in human milk — and sold as a B2B ingredient to consumer brands in women's health, active nutrition, infant & child nutrition, and gut health.

Products and services

  • effera® (Bio-Identical Human Lactoferrin) effera® is the world's first bio-identical human lactoferrin, precision-fermented to be structurally and functionally equivalent to the lactoferrin in mother's milk. Sold B2B to brand formulators in women's health, active nutrition, infant & child nutrition, gut health, longevity, and personal care, with claimed 63% reduction in inflammation in ex vivo studies and 400% better uptake than bovine lactoferrin. The brand is trademarked and is Helaina's flagship product.
  • Helaina Precision Fermentation Platform Proprietary four-step R&D operating system (Design → Build → Assess → Scale) that programs yeast with human genetic instructions to produce bio-identical human proteins. Leverages 170M+ data points of machine learning, advanced robotics and mass spectrometry for parallel strain characterization, and 75,000-liter commercial-scale bioreactors achieving over 99% purity. Operated by 35+ scientists (including 15 PhDs) at Helaina's New York City facility.

Quantifiable outcome

  • 63% reduction in inflammation across all donors in ex vivo human immune cell studies
  • +5 more outcomes

Companies that use Helaina

Customer profile

Named customers12 records

Segments6 records

Ideal customer profiles2 records

Helaina technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Helaina partnerships and signals

Strategic signal

Partnerships

14 partnerships are on record, tiered flagship and core.

  • NestléflagshipStrategic or Co-development Partner · 2 June 2026Multi-year strategic innovation collaboration announced June 2, 2026 to explore the role of new bioactive proteins in early-life nutrition. Pairs Nestlé's expertise in infant nutrition research and innovation with Helaina's precision fermentation platform. Part of Nestlé's broader open innovation strategy. Isabel Bureau-Franz (Head of Nestlé Product Technology Center for Nutrition & Health) and Laura Katz (Helaina Founder/CEO) are quoted publicly. Also covered in WSJ exclusive interview.
  • Amulet (Squared Circles / L Catterton)flagshipChannel Partner/ Reseller/ Distributor · 13 April 2026Squared Circles (partnered with L Catterton) launched Amulet in April 2026 with Daily Cycle Support — a biotech supplement containing bio-identical lactoferrin (effera®) plus creatine. Investors include Maria Sharapova and Gabriela Hearst. Featured on Helaina's Where to Buy page.
  • Kroma WellnesscoreChannel Partner/ Reseller/ Distributor · 1 January 2024Consumer brand partner that has launched products formulated with effera® (e.g., Super Core dairy-free colostrum and related longevity/immunity products). Listed on Helaina's 'Where to Buy' page and featured in Forbes (August 2025).
  • The FeedcoreChannel Partner/ Reseller/ Distributor · 1 January 2024Consumer brand partner selling products formulated with effera® (e.g., Swiss Rx Revitalize supplement for performance/recovery). Featured on Helaina's 'Where to Buy' page.
  • Mitsubishi International Food IngredientscoreChannel Partner/ Reseller/ Distributor · 1 January 2024Distribution/ingredient channel partner for effera® in international markets, leveraging Mitsubishi's global food ingredients network.
  • HealthgevitycoreChannel Partner/ Reseller/ DistributorConsumer brand partner selling ImmunoRestore+ supplement powered by effera®, featured on Helaina's 'Where to Buy' page.
  • Vital WomancoreChannel Partner/ Reseller/ DistributorConsumer brand partner selling 'Human Nature' monthly supplement powered by effera® for women's health, featured on Helaina's 'Where to Buy' page.
  • Kepos (Bellie)coreChannel Partner/ Reseller/ DistributorConsumer brand partner selling 'Human Milk Prebiotic Superfood' (human milk-equivalent) powered by effera®, featured on Helaina's 'Where to Buy' page.
  • Sunny WithincoreChannel Partner/ Reseller/ DistributorConsumer brand partner selling 'Longevity' watermelon-lime liposomal supplement powered by effera®, featured on Helaina's 'Where to Buy' page.
  • Desert HarvestcoreChannel Partner/ Reseller/ DistributorConsumer brand partner selling 'Human Lactoferrin with SSAV' supplement for menopause support powered by effera®; entered European menopause market September 2025. Featured on Helaina's 'Where to Buy' page.
  • VEEP NutritioncoreChannel Partner/ Reseller/ DistributorConsumer brand partner selling 'Immunity Code Young Gut Ultra' supplement powered by effera®, featured on Helaina's 'Where to Buy' page.
  • LevellecoreChannel Partner/ Reseller/ DistributorConsumer brand partner selling cycle-syncing plant-based protein (Boom Chocolata) powered by effera®, featured on Helaina's 'Where to Buy' page.
  • Vital NutrientscoreChannel Partner/ Reseller/ DistributorConsumer brand partner selling 'Mighty Multivitamin Without Iron' for kids using effera®, featured on Helaina's 'Where to Buy' page.
  • Silver FerncoreChannel Partner/ Reseller/ DistributorConsumer brand partner selling 'Women's Whole Food Multivitamin' formulated with effera®, featured on Helaina's 'Where to Buy' page.

Scale indicators12 records

Recent moves6 records

Expansion highlights8 records

Helaina competitors and assessment

Company assessment

Direct peers

  • Perfect Day: Direct precision fermentation peer producing bio-identical dairy proteins (whey and casein) via engineered microorganisms; comparable B2B ingredient model, fermentation platform, and CPG brand partner go-to-market as Helaina.
  • Remilk: Precision fermentation company producing animal-free milk proteins for food and beverage applications; overlaps with Helaina in B2B bioactive protein production using engineered yeast and similar capital-intensive scale-up profile.
  • TurtleTree: Biotech developing precision-fermented lactoferrin and other human milk proteins for infant nutrition and functional foods; one of the closest direct competitors to Helaina's effera® in the bio-identical lactoferrin category.
  • Imagindairy: Israel-based precision fermentation company producing animal-free dairy proteins using engineered microbes; comparable B2B ingredient model, fermentation stack, and food/beverage brand partner strategy as Helaina.

Emerging players

  • 108Labs: Cellular agriculture / precision fermentation company targeting human breast milk components; comparable focus on bio-identical human milk proteins for early-life nutrition but at earlier commercial stage than Helaina.
  • Biomilq: Cellular agriculture company cultivating milk components from mammary cells; comparable mission of producing human-milk-equivalent proteins for infant formula but uses a different (cell-culture) production modality than Helaina's precision fermentation.

Broad incumbents

  • Bioseutica: One of the world's largest suppliers of bovine lactoferrin and egg-derived proteins to nutrition, supplement, and infant formula markets; direct incumbent competitor that Helaina's bio-identical human lactoferrin explicitly displaces.
  • Arla Foods Ingredients: Major dairy-ingredient supplier offering whey proteins, caseins, and lactoferrin for infant nutrition, sports nutrition, and health; broad incumbent whose bovine lactoferrin and dairy protein portfolio competes directly with effera® in B2B ingredient procurement.
  • Glanbia Nutritionals: Global ingredient supplier with a sizable lactoferrin and bioactive protein portfolio serving supplement and functional food brands; comparable B2B ingredient distribution muscle that Helaina's brand partners could alternatively purchase from.

Others

  • Nestlé Health Science: Strategic partner and global nutrition/health sciences arm of Nestlé; relevant as both a customer (multi-year collaboration) and a broad incumbent defining the regulatory, formulation, and commercialization standards Helaina must meet in early-life nutrition.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Helaina social profiles

Digital presence

Helaina financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Helaina leadership team

Management profile

Number of profiles

Profiles9 records

Helaina funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors13 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Helaina M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Helaina

What does Helaina do?

Helaina produces and sells effera®, the world's first bio-identical human lactoferrin, manufactured via proprietary precision fermentation. The company operates a B2B ingredient model, supplying brand formulators and consumer packaged goods companies in women's health, sports and active nutrition, infant and child nutrition, gut health, and longevity. A flagship multi-year strategic collaboration with Nestlé extends the platform's reach into early-life nutrition.

Is Helaina a public or private company?

Helaina is a private company. It is classified as venture growth investor backed and is currently operating.

When was Helaina founded?

Helaina was founded in 2019. It employs 11 to 50 people.

Where is Helaina based?

Helaina is headquartered in New York, United States, in the North America region.

How does Helaina make money?

Two revenue lines are on record. B2B ingredient sales (effera® human lactoferrin) is the primary driver. The others are strategic co-development partnerships / licensing.

Who are Helaina's main competitors?

Direct peers on record are Perfect Day, Remilk, TurtleTree and Imagindairy. Emerging players are 108Labs and Biomilq. Broad incumbents are Bioseutica, Arla Foods Ingredients and Glanbia Nutritionals. Nestlé Health Science is listed as an others.

Does Helaina have an API?

No public API is recorded for Helaina.

What industry is Helaina in?

Helaina's product category is Bioactive Protein Ingredients. Its primary akta.pro industry code is AFAKAKAJ, Infant Formula & Specialized Dairy Nutrition Manufacturing, with a secondary code of AFAHAHAJ, Specialized Dairy Nutrition Base Powder & Premix Manufacturing (Vitamin/Mineral/Functional Premixes). Its NAICS code is 3115 and its SIC code is 2020.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Food Business NewsNestle reigns as leading brandBrand Finance ranked Nestle as the world's most valuable food brand, with its value rising 23% to $24.58 billion. Lay's followed at $15.10 billion, and Yili led dairy brands at $14.50 billion. The report notes brands are shifting toward health-focused innovations and portfolio flexibility.foodnavigator.comThe rise and rise of precision-fermented lactoferrinPrecision fermentation technology is enabling the mainstream production of lactoferrin, a protein with immunity and gut health benefits traditionally sourced from cow's milk, with companies scaling both bovine and human variants through genetically engineered micro-organisms. Key players including Nestlé (partnering with Helaina), Novonesis (partnering with Turtle Tree), and Vivici are driving commercialization, with the lactoferrin market projected to reach $810.11 million by 2034. Vivici received a €12.5 million grant from the European Innovation Council Accelerator Program in June 2026 to scale up production, while Turtle Tree and All G have both secured FDA GRAS 'no questions' status for their bovine lactoferrin products.The Globe and MailWhy this Canadian entrepreneur wants to rewrite the rules of infant nutritionNestlé announced a multiyear partnership with Helaina to buy lactoferrin, a breast-milk protein, and advance infant nutrition. Helaina, founded by Laura Katz, has raised $93 million and uses precision fermentation to produce bioidentical lactoferrin. The partnership details are scarce, but the protein is not yet available for infant formula.PlanetfoodNestlé Bets on Precision Fermentation as Infant Nutrition Enters a New EraNestlé has backed US biotech company Helaina, which uses precision fermentation to produce proteins found in human breast milk for infant nutrition products. The partnership gives Nestlé access to emerging biotechnology capabilities without developing them internally, reflecting a wider shift in the global food sector toward specialized nutrition products. Precision fermentation is increasingly being viewed as a manufacturing platform capable of producing proteins, fats, enzymes, and bioactive compounds for food, health, and wellness applications.Just FoodNestlé to work with US start-up on infant-formula NPDNestlé announced a multi-year partnership with US start-up Helaina to explore bioactive proteins in infant formula. Helaina's first product is Effera, a lactoferrin protein bioidentical to the human form. No further details on contract length were disclosed.GreenqueenNestlé, Helaina to Develop Baby Formula with Breast Milk ProteinNestlé has entered a multi-year collaboration with New York-based startup Helaina to research bioactive proteins and develop infant formula using Helaina's precision-fermented human lactoferrin ingredient called effera. The partnership combines Helaina's synthetic biology platform with Nestlé's expertise in early-life nutrition, aiming to close the nutritional gap between formula and breast milk while providing a safer, more consistent supply chain. The collaboration comes after Nestlé's recent product recall affecting over 60 countries and targets the estimated 130 million babies globally who rely on formula at some point.WsjNestlé Partners With Startup Helaina to Develop Infant Formula With Human ProteinsNestlé entered a multiyear partnership with U.S. startup Helaina to develop infant formula using proteins identical to those in human breast milk. The collaboration follows a tainted-ingredient crisis in Nestlé's infant nutrition business.MorningstarNestle Partners With Startup Helaina to Develop Infant Formula With Human ProteinsNestle entered a multiyear partnership with U.S. startup Helaina to develop infant formula using proteins identical to those in human breast milk. Helaina has raised over $95 million and is working to scale its lactoferrin production. The partnership follows a tainted-ingredient crisis that hit Nestle's infant nutrition business.MarketScreenerNestle Partners With Startup Helaina to Develop Infant Formula With Human ProteinsNestle entered a multiyear partnership with U.S. startup Helaina to develop infant formula using proteins identical to those in human breast milk. Helaina has raised over $95 million and is scaling its lactoferrin production technology. The partnership follows a tainted-ingredient crisis that hit Nestle's infant nutrition business.HomepageSupplement Brand Amulet Launches with Investor Backing from Maria Sharapova, Partners with HelainaAmulet, a new hormonal health company backed by investors including Maria Sharapova and Gabriela Hearst, has launched its flagship product Daily Cycle Support — a supplement combining precision-fermented human lactoferrin (effera) sourced from New York biotech Helaina with creatine monohydrate for women's hormonal health. The product represents one of the first consumer applications of precision-fermented human proteins in a women's health supplement, marking a shift toward ingredients engineered specifically for female biology. Amulet is led by CEO Suzanne Stockbridge and operates as a Squared Circles company partnered with L Catterton.